{"status": "ok", "totalResults": 1, "articles": [{"source": {"id": null, "name": "Astrazeneca.com"}, "author": null, "title": "Tagrisso plus chemotherapy demonstrated strong improvement in progression-free survival for patients with EGFR-mutated advanced lung cancer in FLAURA2 Phase III trial - AstraZeneca", "description": "", "url": "https://www.astrazeneca.com/media-centre/press-releases/2023/tagrisso-plus-chemo-improved-pfs-in-lung-cancer.html", "urlToImage": "", "publishedAt": "2023-05-17T01:30:00Z", "content": "Positive high-level results from the FLAURA2 Phase III trial showed AstraZenecas Tagrisso (osimertinib) in combination with chemotherapy demonstrated a statistically significant and clinically meanin\u2026 [+7669 chars]"}]}